1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-3-carboxylic acid

Catalog No. :
ACWNQB362
CAS No. :
1411766-55-6
Molecular Formula :
C13H14N2O4S2
Molecular Weight :
326.40

IUPAC Name:1-(benzo[d]thiazol-2-ylsulfonyl)piperidine-3-carboxylic acid

1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$86.00Login to see priceIn stockInquiry
250mg97%$144.00Login to see priceIn stockInquiry
1g97%$389.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-3-carboxylic acid
IUPAC Name1-(benzo[d]thiazol-2-ylsulfonyl)piperidine-3-carboxylic acid
MDL No.MFCD22574905
Molecular FormulaC13H14N2O4S2
Molecular Weight326.40
SMILESO=C(C1CN(S(=O)(C2=NC3=CC=CC=C3S2)=O)CCC1)O
InChI KeyJHVNINGFPKKLCZ-UHFFFAOYSA-N
Synonym1-(Benzothiazole-2-sulfonyl)-piperidine-3-carboxylic acid;3-Piperidinecarboxylic acid, 1-(2-benzothiazolylsulfonyl)-;1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-3-carboxylic acid
CAS No.1411766-55-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWNQB362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWNQB362 route product structure diagram
    ACWNQB3621411766-55-6 In Stock
Inquiry

2. ACWNQB362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEJHQ928 route compound structure diagram
    ACEJHQ928498-95-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWNQB362 route product structure diagram
    ACWNQB3621411766-55-6 In Stock
Inquiry

Comments (0)